Lovely Brother (2)
Release time:
2020-07-22
lovely brother (two)
my brother is a lovely baby.
He's just four months old, white face, big eyes, long eyelashes.
He likes eating hands very much. The way he ate his hand was peculiar, not with one finger, but with the whole fist in his mouth.
He likes to blow saliva with his mouth "puff " , and he also likes me to talk to him. No matter what I say, he will laugh "cackle " . His response is very sensitive. As long as he hears the sound, he quickly turns his head to look for the place where the sound is made. The curious eyes make me feel very funny and cute.
I like my brother very much!
Spring Park
Spring is coming, spring is coming, spring is a vibrant season.
I came to Wuzhou Park. Tulips under Rainbow Bridge were in full bloom. There were yellow, red and red and white. The breeze blew, and the tulips in full bloom were nodding to us like lovely smiling faces.
There are a large number of golden rape flowers on the river, which look like bright stars from a distance. They emit a burst of flowers, attracted many industrious little bees. Lovely bees are dancing their wings among the flowers, happily picking nectar.
There are willows with green leaves on the bank of the river. The willow branches swing with the wind, like a little girl dancing lightly.
I love the vibrant spring, I love the spring park!
Little Ants Crossing the River
Once upon a time, there was a little ant who wanted to eat apples, but a small river blocked its way because apple trees grew on the other side of the river. The little ant really wants to eat the red apple, but it can't swim and can't reach the other side. What should I do?
Small ants think of a way. It brought a few branches and intended to make a boat, but found that it could not make a boat without nails. The little ant had no choice but to give up this method and continue to think of ways.
At this time, a breeze blew and a large leaf fell in front of the ant. The little ant jumped with joy. It lifted the big leaves and pushed the big leaves into the river. The big leaves immediately turned into a small boat!
The little ant jumped onto the boat gently and immediately picked up the branch and rowed hard. After reaching the other side, the little ant picked a lot of apples.
I like this little ant that loves thinking! (He Yuxi) (The author is the daughter of Zheng Junwei, Quality Department of Pharmaceutical Company)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31